Annovis Bio, Inc. (ANVS) vs Serina Therapeutics, Inc. (SER)
Annovis Bio, Inc. and Serina Therapeutics, Inc. are both Biotechnology companies. Annovis Bio, Inc. and Serina Therapeutics, Inc. are of similar size ($56.8M and $54.4M). Across the 8 metrics below, Serina Therapeutics, Inc. leads on 6 and Annovis Bio, Inc. on 2.
Valuation
Profitability
| Metric | ANVS | SER | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (703.68%) | (306.22%) | (57.72%) |
| Return on assets | (227.74%) | (136.00%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack